DRKS00034686RecruitingNot Applicable
Detection of circulating tumor in lymphoma patients using dPCR-based liquid biopsy in clinical routine, an observational study
niversitätsklinikum Freiburg Medizinische Klinik I0 sites400 target enrollmentStarted: August 6, 2024Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 400
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- All
Inclusion Criteria
- •Suspected CNS-lymphoma, suspected lymphoma progression or MRD monitoring lymphoma
Exclusion Criteria
- •< 18 years
Investigators
Similar Trials
Recruiting
Not Applicable
The detection of cells originating from thyroid nodules in bloodstreamNeoplasmsKCT0008179Seoul National University Bundang Hospital300
Completed
Not Applicable
A study on the detection of circulating tumor cells (CTC) in patients with resected pulmonary metastases from colorectal cancer and its clinical significance as a biomarkerPulmonary metastases from colorectal cancerJPRN-UMIN000017460Kawasaki Medical School, Department of General Thoracic Surgery5
Recruiting
Not Applicable
A study on the detection of circulating tumor cells (CTCs) in patients with hepatocellular carcinoma and its clinical significanceHepatocellular carcinomaJPRN-UMIN000025989Hiroshima university100
Completed
Not Applicable
Circulating tumour cells by diagnostic leukapheresis mirror primary tumour heterogeneity in non-small cell lung cancerlung cancerlung carcinomanon small cell lungcarcinoma10038666NSCLCNL-OMON43511niversitair Medisch Centrum Groningen80
Not yet recruiting
Not Applicable
Circulating tumour cells by diagnostic leukapheresis mirror primary tumour heterogeneity in non-small cell lung cancercirculating tumour cells (CTC)Non small cell lung carcinoma (NSCLC)Diagnostic leukapheresis (DLA)tumour heterogeneitycirculerende tumor cellen (CTC)niet kleincellig long carcinoom (NSCLC)diagnostische leukopherese (DLA)tumor heterogeniteitNL-OMON19904Sponsor: Innovative Medicine initiativeperformer: UMCG80